Bonne J. Adams - Feb 1, 2023 Form 3 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role: Chief Operating Officer
Signature: /s/ Scott B. Brown, Attorney-in-Fact
Stock symbol: TCON
Transactions as of: Feb 1, 2023
Transactions value $: $0
Form type: 3
Date filed: 2/9/2023, 08:26 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TCON	Common Stock						4.27K	Feb 1, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TCON	Employee Stock Options (Right to Buy)							Feb 1, 2023	Common Stock	516	$13.35	Direct	F3
holding	TCON	Employee Stock Options (Right to Buy)							Feb 1, 2023	Common Stock	1.36K	$13.35	Direct	F4
holding	TCON	Employee Stock Options (Right to Buy)							Feb 1, 2023	Common Stock	2.02K	$70.43	Direct	F5
holding	TCON	Employee Stock Options (Right to Buy)							Feb 1, 2023	Common Stock	1.08K	$70.43	Direct	F5, F6
holding	TCON	Employee Stock Options (Right to Buy)							Feb 1, 2023	Common Stock	4.12K	$146.20	Direct	F7
holding	TCON	Employee Stock Options (Right to Buy)							Feb 1, 2023	Common Stock	5.5K	$51.50	Direct	F8
holding	TCON	Employee Stock Options (Right to Buy)							Feb 1, 2023	Common Stock	6.59K	$21.50	Direct	F9
holding	TCON	Employee Stock Options (Right to Buy)							Feb 1, 2023	Common Stock	12.5K	$7.90	Direct	F10
holding	TCON	Employee Stock Options (Right to Buy)							Feb 1, 2023	Common Stock	17.6K	$4.02	Direct	F11
holding	TCON	Employee Stock Options (Right to Buy)							Feb 1, 2023	Common Stock	55K	$9.14	Direct	F12
holding	TCON	Employee Stock Options (Right to Buy)							Feb 1, 2023	Common Stock	80K	$2.32	Direct	F13

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 3,500 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2021.
F2	Includes 767 of the 2,595 restricted stock units granted to the Reporting Person on January 21, 2016. 1/4th of the award vested annually on each anniversary date of the grant. The Reporting Person sold the other 1,828 restricted stock units following settlement and prior to being required to report pursuant to Section 16(a) of the Securities Exchange Act of 1934, as amended.
F3	The shares subject to the option vest and become exercisable in 48 equal monthly installments commencing March 14, 2013.
F4	The shares subject to the option vest and become exercisable in 48 equal monthly installments commencing May 23, 2013.
F5	1/4th of the shares subject to this option shall vest on the first anniversary of October 3, 2014. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month.
F6	The shares subject to this option will be forfeited if the Company's initial public offering is not completed on or before March 31, 2015.
F7	1/4th of the shares subject to this option shall vest on the first anniversary of March 25, 2015. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month.
F8	1/4th of the shares subject to this option shall vest on the first anniversary of January 20, 2017. The remaining shares vest and become exercisable in 36 equal monthly installments on the 20th of each month thereafter.
F9	1/4th of the shares subject to this option shall vest on the first anniversary of February 21, 2018. The remaining shares vest and become exercisable in 36 equal monthly installments on the 21st of each month thereafter.
F10	1/4th of the shares subject to this option shall vest on the first anniversary of January 29, 2019. The remaining shares vest and become exercisable in 36 equal monthly installments on the 29th of each month thereafter.
F11	1/4th of the shares subject to this option shall vest on the first anniversary of January 31, 2020. The remaining shares vest and become exercisable in 36 equal monthly installments on the 31st of each month thereafter.
F12	1/4th of the shares subject to this option shall vest on the first anniversary of January 29, 2021. The remaining shares vest and become exercisable in 36 equal monthly installments on the 29th of each month thereafter.
F13	1/4th of the shares subject to this option shall vest on the first anniversary of January 28, 2022. The remaining shares vest and become exercisable in 36 equal monthly installments on the 28th of each month thereafter.